|
MLTX
|
US |
MOONLAKE IMMUNOTHERAPEUTICS |
8,494,151 |
$460M |
25.26% |
-
|
- |
|
PRAX
|
US |
PRAXIS PRECISION MEDICINES I |
1,693,219 |
$130M |
7.16% |
94.6%
|
- |
|
JANX
|
US |
JANUX THERAPEUTICS INC |
2,100,000 |
$112M |
6.17% |
100.0%
|
- |
|
ACLX
|
US |
ARCELLX INC |
1,300,000 |
$100M |
5.48% |
4.0%
|
- |
|
EWTX
|
US |
EDGEWISE THERAPEUTICS INC |
3,406,534 |
$91M |
5.00% |
-
|
- |
|
NAMS
|
US |
NEWAMSTERDAM PHARMA CO NV |
3,250,000 |
$84M |
4.59% |
31.6%
|
- |
|
EYPT
|
US |
EYEPOINT PHARMACEUTICALS INC |
8,325,000 |
$62M |
3.41% |
-
|
- |
|
RAPP
|
US |
RAPPORT THERAPEUTICS INC |
2,940,921 |
$52M |
2.87% |
-
|
- |
|
CRNX
|
US |
CRINETICS PHARMACEUTICALS IN |
1,000,000 |
$51M |
2.81% |
-9.1%
|
- |
|
INSM
|
US |
INSMED INC |
650,000 |
$45M |
2.46% |
30.0%
|
- |
|
BBIO
|
US |
BRIDGEBIO PHARMA INC |
1,600,000 |
$44M |
2.41% |
-13.9%
|
- |
|
CNTA
|
US |
CENTESSA PHARMACEUTICALS-ADR |
2,561,600 |
$43M |
2.36% |
-
|
- |
|
DRUG
|
US |
BRIGHT MINDS BIOSCIENCES INC |
1,059,331 |
$38M |
2.10% |
100.0%
|
- |
|
PCVX
|
US |
VAXCYTE INC |
425,000 |
$35M |
1.91% |
-57.5%
|
- |
|
MRUS
|
US |
MERUS NV |
740,000 |
$31M |
1.71% |
-
|
- |
|
HLXB
|
US |
HELIX ACQUISITION CORP II |
2,909,000 |
$31M |
1.68% |
-
|
- |
|
RNA
|
US |
AVIDITY BIOSCIENCES INC |
1,050,000 |
$31M |
1.68% |
-
|
- |
|
PHVS
|
US |
PHARVARIS NV |
1,466,460 |
$28M |
1.54% |
-
|
- |
|
CRBP
|
US |
CORBUS PHARMACEUTICALS HOLDI |
2,375,000 |
$28M |
1.54% |
-
|
- |
|
TARS
|
US |
TARSUS PHARMACEUTICALS INC |
500,000 |
$28M |
1.52% |
-
|
- |